Skip to main content
Future Journal of Pharmaceutical Sciences

Table 8 Robustness of ertugliflozin (n=6)

From: Novel stability-indicating RP-UPLC method for simultaneous estimation of sitagliptin and ertugliflozin in bulk and pharmaceutical formulations

Parameter

Peak area (mean±SD)

%RSD

Flow rate minus

584073.2±5999.8

1.0

Flow rate plus

351840.2±1790.2

0.5

Mobile phase minus

432139.7±848.2

0.2

Mobile phase plus

435316±4885.4

1.1

Thermal minus

444698±1610.8

0.4

Thermal plus

356581.5±717.5

0.2

  1. n number of determinations, SD standard deviation, RSD relative standard deviation
Back to article page